What is INDV's health score?

Indivior Pharmaceuticals, Inc. (INDV) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is INDV's estimated fair value?

Based on our 5-year discounted cash flow model, Indivior Pharmaceuticals, Inc.'s estimated fair value is $39.82 per share, representing a 5.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is INDV undervalued or overvalued?

Our model currently rates INDV as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for INDV... Refresh in a moment for the full analysis.

Indivior Pharmaceuticals, Inc. (INDV)

Healthcare Fair Value low mixed

$37.62

Updated: 2026-06-06

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

60 Healthy

Relative Value

30 Weak

Capital Allocation

45 Mixed

Risk

50 Mixed

Est. Fair Value $39.82

DCF Upside +5.9%

Sector Rank #3030 of 6695

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Altman Z-Score in distress zone — elevated bankruptcy risk

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.